Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Huntington’s Disease Treatment Market, by Drug Type
1.4.2 North America Huntington’s Disease Treatment Market, by Distribution Channel
1.4.3 North America Huntington’s Disease Treatment Market, by Age
1.4.4 North America Huntington’s Disease Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Huntington’s Disease Treatment Market by Drug Type
4.1 North America Approved Drugs Market by Region
4.2 North America Huntington’s Disease Treatment Market by Approved Drugs Type
4.2.1 North America Tetrabenazine Market by Country
4.2.2 North America Deutetrabenazine Market by Country
4.3 North America Offlabel Drugs Market by Region
Chapter 5. North America Huntington’s Disease Treatment Market by Distribution Channel
5.1 North America Hospital Pharmacies Market by Country
5.2 North America Drug Store & Retail Pharmacies Market by Country
5.3 North America Online Pharmacies Market by Country
Chapter 6. North America Huntington’s Disease Treatment Market by Age
6.1 North America Below 50 years Market by Country
6.2 North America Above 50 years Market by Country
Chapter 7. North America Huntington’s Disease Treatment Market by Country
7.1 US Huntington’s Disease Treatment Market
7.1.1 US Huntington’s Disease Treatment Market by Drug Type
7.1.1.1 US Huntington’s Disease Treatment Market by Approved Drugs Type
7.1.2 US Huntington’s Disease Treatment Market by Distribution Channel
7.1.3 US Huntington’s Disease Treatment Market by Age
7.2 Canada Huntington’s Disease Treatment Market
7.2.1 Canada Huntington’s Disease Treatment Market by Drug Type
7.2.1.1 Canada Huntington’s Disease Treatment Market by Approved Drugs Type
7.2.2 Canada Huntington’s Disease Treatment Market by Distribution Channel
7.2.3 Canada Huntington’s Disease Treatment Market by Age
7.3 Mexico Huntington’s Disease Treatment Market
7.3.1 Mexico Huntington’s Disease Treatment Market by Drug Type
7.3.1.1 Mexico Huntington’s Disease Treatment Market by Approved Drugs Type
7.3.2 Mexico Huntington’s Disease Treatment Market by Distribution Channel
7.3.3 Mexico Huntington’s Disease Treatment Market by Age
7.4 Rest of North America Huntington’s Disease Treatment Market
7.4.1 Rest of North America Huntington’s Disease Treatment Market by Drug Type
7.4.1.1 Rest of North America Huntington’s Disease Treatment Market by Approved Drugs Type
7.4.2 Rest of North America Huntington’s Disease Treatment Market by Distribution Channel
7.4.3 Rest of North America Huntington’s Disease Treatment Market by Age
Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sun Pharmaceutical Industries Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Hikma Pharmaceuticals PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
8.5.1 Company Overview
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Neurocrine Biosciences Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.9 Pfizer, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional & Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. F. Hoffmann-La Roche Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Unique Offerings 